JUNSHI BIO (01877) completes issuance of 300 million yuan technology innovation bonds.
Kingmed Diagnostics (01877) announced that the company has recently completed the issuance of the second tranche of technology innovation bonds for the year 2026, with the funds raised being received on July 22, 2026. The total amount raised for the second tranche of technology innovation bonds for the year 2026 is 300 million RMB, with a maturity of 3 years and due on July 22, 2029, and an issuance interest rate of 2.59%.
JUNSHI BIO (01877) announced that the company has recently completed the issuance of the second tranche of technology innovation bonds for the year 2026, with funds raised credited to their account on July 22, 2026. The total amount raised for the second tranche of technology innovation bonds for the year 2026 is RMB 300 million, with a maturity period of 3 years and set to expire on July 22, 2029. The issued interest rate is 2.59%.
Related Articles
TIANGONG INT'L (00826) was granted a total loan of HKD 79.29 million.
DongGuan YuTong Optical Technology (300790.SZ) plans to repurchase company shares in the amount of 30 million to 60 million yuan.
OSHIDORI (00622) announces profit growth, expecting first-half net profit to exceed HK$150.7 million, a year-on-year increase of 59%.
TIANGONG INT'L (00826) was granted a total loan of HKD 79.29 million.
DongGuan YuTong Optical Technology (300790.SZ) plans to repurchase company shares in the amount of 30 million to 60 million yuan.
OSHIDORI (00622) announces profit growth, expecting first-half net profit to exceed HK$150.7 million, a year-on-year increase of 59%.
RECOMMEND
